Abstract
INTRODUCTION
There is a large spectrum of mitral valve abnormalities in the congenital population, and surgical techniques are still being perfected. Mitral valve disease can also be associated with other cardiac anomalies and long-term prognosis can vary. Major disadvantages following mitral valve replacement are related to the morbidity associated with long-term anticoagulation and thromboembolic complications, prosthetic valve thrombosis, infective endocarditis, reduced survival and patient-prosthesis mismatch as the small child grows with the inevitable need for subsequent prosthesis replacement [1] [2] [3] . Mitral repair is described as a better option than valvular replacement when adequate reconstruction can be achieved [1, 4] . However, surgical repair techniques are diverse and heterogeneous, and postoperative results at midterm follow-up are not well described in the literature [5] [6] [7] [8] .
Surgical outcomes are influenced by various elements, but adequacy of repair is certainly a key factor to assess. The Technical Performance Score (TPS), which measures residual disease after a planned repair, has previously been found to be a valid tool to predict postoperative mortality, morbidities and post-discharge reinterventions following various cardiac procedures in congenital patients [9, 10] . Moreover, intraoperative recognition and immediate intervention on residual defects resulted in improved outcomes compared with delayed postoperative reintervention [11] .
Therefore, the purpose of this study was to describe factors associated with unsuccessful mitral valve repair, describe procedural outcomes and to specifically validate the TPS as a predictor of midterm outcomes.
MATERIALS AND METHODS

Data collection
The study protocol was approved by the institutional review board and requirement for patient consent was waived.
A review of all consecutive patients from January 2000 to December 2013 who underwent mitral valve repair in a single high-volume centre was conducted. Over the study period, 9 surgeons with different experience level were directly involved in patient care and surgery. Median follow-up duration was 3.0 years (interquartile range 0.6-6.1 years). A total of 2271 personyears of clinical data were accrued. For the purpose of the study, the follow-up period was closed on December 2014 and terminal event at follow-up was available for 71% of patients. We included patients who underwent primary mitral valve repair, mitral reoperations and combined mitral repair with other concomitant intracardiac procedures. Patients presenting with mitral valve disease who previously underwent surgery for complete atrioventricular canal defect were included, but mitral surgery as part of primary repair of complete atrioventricular canal defect was excluded.
Surgical case complexity was determined following the Risk Adjustment for Congenital Heart Surgery (RACHS-1) classification. Risk category for combined operations was selected according to the greatest risk of any of the sub-procedure. Most patients were in RACHS-1 category 3, but more complex pathologies were also encountered. We created 2 complementary groups for patients who were not suitable for the predefined RACHS-1 categories. Category 7 included patients <18 years with complex pathologies and included procedures such as complex aortic procedure, hybrid procedures or staged left ventricle recruitment. Category 8 was assigned to all adult congenital patients with malformations of the mitral valve.
Each procedural outcome was graded following predetermined TPS criteria based on detailed postoperative echocardiographic assessment of the mitral valve. Only the mitral valve was graded and other concomitant procedures were not evaluated. Discharge TPS Class 1 (optimal) denoted patients with no or trivial mitral stenosis and/or regurgitation. TPS Class 2 (adequate) represented mild residual mitral stenosis and/or regurgitation. Lastly, TPS Class 3 (inadequate) included patients with > _moderate mitral stenosis and/or regurgitation, any mitral reintervention (surgery or catheter-based procedure) for major residua prior to discharge or permanent pacemaker insertion for new onset third-degree atrioventricular block (Supplementary Material, Table S1 ). In some instances, a complete echocardiogram was not performed (n = 58) prior to discharge and in which case, we used a detailed intraoperative post-cardiopulmonary bypass echocardiographic with early post-discharge echocardiographic imaging results to grade the mitral repair. Mitral surgery that necessitated an immediate second cardiopulmonary bypass run for mitral revision was considered TPS Class 2 even if predischarge imaging measurements were judged optimal.
Outcomes
Our primary study end-points were mitral valve reintervention (percutaneous or surgery), transplantation and mortality at midterm follow-up.
Early mortality was defined as death (or transplantation) occurring prior to hospital discharge, regardless of hospital length of stay. For patients discharged home <30 days postoperatively, early mortality was defined as death (or transplantation) occurring <30 days after mitral valve repair. For patients with longer postoperative length of stay (>30 days) after mitral repair, we defined late mortality as death (or transplantation) occurring at any time after hospital discharge.
Early reinterventions consisted of any mitral valve procedure (percutaneous or surgery) performed before discharge following the index mitral valve procedure, regardless of hospital length of stay. Immediate intraoperative revision of mitral repair was not considered a reintervention as it was performed in the same index operation.
Late reinterventions consisted of any mitral valve procedure (percutaneous or surgery) to treat any residual or recurrent mitral pathology that occurred any time after hospital discharge from the index mitral repair.
The following major postoperative adverse events were also recorded: severe neurologic complications (stroke, seizures and intracranial haemorrhages), deep sternal wound infection, sternal re-exploration for mediastinal bleeding or low cardiac output syndrome, extracorporeal membrane oxygenation for low cardiac output state or cardiac failure, diaphragmatic plication for phrenic nerve injury, vocal cord paralysis and prolonged ventilation (>7 days).
Statistical analysis
Categorical variables are reported as count and percentage. Continuous variables are presented as mean ± standard deviation or median with interquartile range. Fisher's exact test and v 2 tests (when the cell count was below 5) were used to compare and explore various categorical patient characteristics and the technical performance scores with the valvular outcomes. Non-parametric estimates of time-related events such as freedom from postdischarge mitral reintervention and midterm transplant-free survival were calculated using the Kaplan-Meier estimator and the log-rank test was used for comparisons. Patients for whom a time-related event had not occurred were censored at their last visit.
Cox proportional hazard modelling was used to identify independent factors associated with post-discharge mitral reinterventions and mortality. Variables explored for the model for postdischarge mitral reinterventions were chosen following univariable analysis: postoperative TPS, age, body surface area, gender, immediate intraoperative mitral repair revision, previous cardiac surgery, previous mitral valve surgery, previous catheter intervention, genetic disorder, major concomitant intracardiac repair, cardiac physiology (single or biventricular circulation), prematurity, mitral valve haemodynamic (preoperative severity of mitral regurgitation and mitral stenosis) and RACHS-1 category.
Variables explored for the model for mortality were postoperative TPS, age, post-discharge mitral valve reintervention, major concomitant intracardiac procedure and cardiac physiology.
Surgeon identity was not associated with the outcomes on univariable analysis and was therefore not included in the Cox models. Nine surgeons performed mitral repair at various time interval over the study period. Annual caseload volume varied considerably, from 4 cases/year to 21 cases/year. Case complexity was also very heterogeneous. The most active surgeons encountered patients with higher RACHS-1 categories and more patients with history of mitral procedure.
Proportional hazard assumption was assessed with graphical evaluation using log-log survival curves and using a formal significance test based on Schoenfeld residuals and scaled Schoenfeld residuals. Statistical significance was defined with a P-value <0.05. Statistical analyses were conducted using Stata version 13 (Stata Corp, College Station, TX, USA).
RESULTS
A total of 587 patients underwent mitral valve repair from January 2000 to December 2013 and were retrospectively included in our study. Median age of our cohort was 2.6 years (interquartile range 0.6-9.6). There were 190 (32%) patients younger than 12 months and 51 (9%) adult congenital patients. Two hundred and eighty-four (48%) patients previously underwent open-heart surgery, and 153 patients had history of prior mitral repair. Baseline patient characteristics are summarized in Table 1 . Most patients (n = 486, 83%) were in RACHS-1 category 3 and major concomitant intracardiac procedures were frequently performed (n = 443, 75.5%) at the time of the index mitral repair. Detailed perioperative characteristics are listed in Table 2 .
Early outcomes
Immediate intraoperative mitral revision was performed in 35 (6%) patients and the majority (n = 29) did not require further reintervention on the mitral valve during the same hospitalization. Of these 35 patients, discharge TPS was adequate in 21 (60%) and inadequate in 14 (40%) patients (Supplementary Material, Fig. S1 ). Major postoperative complications (major postoperative adverse events excluding predischarge reinterventions or permanent pacemaker for complete heart block) occurred in 66 (11.2%) patients. Early mortality was 1.2% (n = 7): 30-day mortality was 0.5% (n = 3) and 4 (0.7%) patients died following a protracted hospital course. Early postoperative cardiac reintervention (excluding immediate intraoperative revision) was required in 31 (5.3%) patients for major residual mitral disease prior to discharge: mitral re-repair was performed in 20 patients, replacement in 6 patients and transcatheter intervention in 5 patients. These patients were therefore scored as TPS 3. A permanent pacemaker was implanted in 18 (3.1%) patients for complete heart block and these were also graded TPS 3. Discharge TPS was optimal in 108 (19%), adequate in 344 (60%) and inadequate in 120 (21%) patients. Thus, in 102 (17.4%) subjects, TPS 3 could be attributed to major residua in their postoperative echocardiogram (71 at discharge and 31 predischarge reintervention). Eight patients did not have a complete echocardiographic assessment and TPS was not assigned.
Late mitral reinterventions
Post-discharge mitral valve reintervention was required in 125 (21.3%) patients and included catheter intervention in 13 patients, surgery in 93 patients (re-repair in 74 patients and valvular replacement in 19 patients) and 19 patients required both percutaneous and surgical interventions. Of these 125 patients, there was only 1 perioperative death. Ten patients died and 2 patients required cardiac transplantation. Mitral repair outcomes were different at midterm follow-up based on TPS; reinterventions were more frequent as the score worsened (log-rank P-value <0.0001) (Fig. 1A) . Discharge TPS following index mitral surgery for patients who required a late reintervention was optimal in 7 (6%), adequate in 70 (56%) and inadequate in 48 (40%) patients. Mean postoperative follow-up duration between index mitral valve repair and mitral reintervention was 2.2 years. Fortytwo (7%) patients also required other non-mitral cardiac reoperations. Freedom from mitral reintervention was 85.2%, 78.2% and 69.4%, and freedom from mitral valve replacement was 97.1%, 95.8% and 94.9% at 1, 2 and 5 years, respectively (Fig. 1B and Table 3 ). On univariable analysis, discharge TPS 2 (HR 3.3; P = 0.003) and TPS 3 (HR 8.7; P < 0.001) as well as preoperative mitral stenosis (HR 1.7; P < 0.0001) were highly significant for late mitral reintervention. Surgeon identity and immediate intraoperative mitral revision were not independent factors.
On multivariable Cox regression, discharge TPS 2 (HR 3.6; P = 0.02) and TPS 3 (HR 8.7; P < 0.001) were highly associated with mitral reintervention. Major concomitant intracardiac repair (HR 2.1; P = 0.01) was also a predictor of late mitral reintervention. History of previous cardiac interventions were not associated with late mitral procedures (Table 4) . Data are presented as n (%), mean ± SD or median (interquartile range). 
Late mortality
Of the 587 patients, there were 26 late deaths and 5 transplantations. Of these 31 patients, discharge TPS from index mitral surgery was optimal in 2, adequate in 15 and inadequate in 14 patients. Survivorship was different at midterm follow-up based on the TPS (log-rank P-value = 0.003) and more patients died in the inadequate group ( Fig. 2A) . Transplant-free survival was 97.8%, 95.3% and 93.2% at 1, 2 and 5 years, respectively ( Fig. 2B and Table 3) . On univariable analysis, discharge TPS 3, but not Class 2, was a significant predictor of mortality at midterm follow-up (HR 6.0; P = 0.02). Late mitral reintervention (percutaneous or surgery) was not associated with mortality (HR 1.7; P = 0.2).
On multivariable Cox regression, only TPS 3 (HR 5.4; P = 0.02) and major concomitant intracardiac repair (HR 2.5; P = 0.04) were associated with decreased post-discharge transplant-free survival (Table 5) .
DISCUSSION
Limited population size of patients with complex heterogeneous pathologies with diverse surgical indications is sine qua non to congenital cardiac surgery. Proper critical evaluation of specific congenital procedures is lacking, and the definition of a successful repair is mainly based on surrogate markers that may not fully represent a technically satisfactory surgery. In light of this, the TPS was first introduced in 2007 to help evaluate the adequacy of cardiac repair following various congenial cardiac procedures [9, 10] . Combined with other factors, the TPS is also used to define the importance of an adequate surgical repair on overall patient outcomes. Moreover, intraoperative technical errors occur frequently in complex congenital patients [12] . These errors may potentially be of greater clinical impact in the postoperative period but may also be mitigated or avoided if they are identified and if their clinical impact is well documented. Thus, TPS not only allows us to evaluate the repair but it also enables selfevaluation and serves as a teaching tool where surgical techniques can be compared. In this retrospective study, we used this score to help determine the adequacy of mitral repair and its relationship to midterm outcomes.
Several mitral valve repair techniques are used in a wide range of pathology and despite this significant variability, TPS 2 and 3 were significantly associated with worse valvular outcomes at midterm follow-up. Freedom from mitral reintervention at 5 years was only 46.3% in patients with TPS Class 3 and 71.7% in TPS Class 2 patients compared with 88.6% in patients with TPS Class 1 mitral repair. Our definition for optimal (TPS 1) mitral repair is strict: at most, trivial mitral regurgitation or stenosis (mean gradient <3 mmHg) is acceptable on discharge echocardiogram. Therefore, every effort should be made to leave the operating room with minimal residual stenosis or regurgitation, even if it requires immediate mitral repair revision during the index mitral operation. Likewise, it was also previously reported that mitral repair reintervention in adults was more frequent with the presence of intraoperative residual (>mild) mitral regurgitation [13, 14] . However, unlike congenital surgery, the adult cardiac surgery literature mainly describes larger cohorts of patients with similar surgical indications and procedures. These more homogeneous groups also likely facilitate the assessment of technical performance following more common procedures. In our cohort, only 2 patients would have fulfilled the echocardiographic criteria for TPS 1 following immediate intraoperative repair revision. Despite a second cardiopulmonary bypass run for mitral re-repair, which is likely a marker of more complex mitral pathology, this immediate revision was not associated with postdischarge mitral reintervention. Other factors such as younger age, single ventricle physiology and concomitant intracardiac interventions were all predictive of post-discharge mitral reoperations. Small patients and neonates have thin and fragile mitral tissue and repair is certainly more challenging [6] . These underlying characteristics represent a complex subgroup of our study population and reinterventions for other cardiac lesions can also be expected. Accordingly, special attention should be given to the mitral valve during more complex surgical correction of pathologies involving other cardiac structures. Increasing severity of mitral stenosis was also associated with post-discharge reintervention. Similarly, another recent study found that young age and preoperative combined mitral regurgitation and stenosis were independent factors for reoperation in a cohort of children [7] .
In our study, the TPS was a predictor of mortality across a wide range of congenital mitral valve disease and surgical techniques. Overall, transplant-free survival for our entire cohort was 93.2% at 5 years and was significantly lower for patients with an inadequate score (87.42%) at discharge. Although mitral reintervention was common over the study period, reoperation was not an independent predictor of mortality. Our results also showed an improved 5-year survival and freedom from mitral replacement compared with a large multi-institutional cohort of paediatric patients who underwent mitral valve replacement [15] . Recently, Yakub et al. [16] showed very similar mortality outcomes at 5 years in a large cohort of older children who underwent mitral repair. However, less than half of their cohort included congenital mitral pathology and few patients with congenital mitral disease were followed for more than 5 years. Most of their patients presented with rheumatic valve disease. This aetiology is not as common in our study and comparison of individual repair techniques may not be completely feasible [4] . A smaller study by Prifti et al. [17] showed a slightly lower survival rate (89.2%) at 5 years in patients with congenital mitral disease. Other cardiac malformations and patients younger than 1 year were predictive of mortality on multivariable analysis.
As shown in previous TPS publications, inadequate cardiac repair and major residua are associated with increased cardiac reinterventions as well as decreased early and late survival in congenital patients [18] [19] [20] . Compared with other studies assessing valvular replacement, survival following mitral repair appears to be superior [2, [21] [22] [23] . Preserving the subvalvular apparatus and ventricular geometry definitely confer some advantages over valvular replacements. In light of these findings, every effort should be made to achieve optimal repair by preserving the native leaflet tissue, which will delay mitral replacement but with the known probability of reintervention. The TPS system can be easily used for mitral valve repair, with or without concomitant procedures, and has now been prospectively applied to patients at our institution.
Limitations
Our research findings should be interpreted with caution, however, in view of the limitations of a retrospective study which included patients from a single institution. Echocardiographic evaluation is certainly subjective, haemodynamic dependent and operator dependent. It was not possible to review each echocardiogram and account for measurement variability. Timing for reintervention and the decision-making to refer patients for a percutaneous or surgical procedure were also not evaluated. There is an extensive range of mitral repair procedures, and we did not evaluate individual repair technique since the primary objective of this study was to evaluate the TPS as a global predictive tool of midterm outcomes following all types of repair.
CONCLUSION
The TPS is a strong predictor of post discharge mitral reintervention following mitral valve repair in a congenital population. Combined end-point of transplantation and death is significantly higher in patients with an inadequate score following mitral valve repair. Nonetheless, overall transplant-free survival is satisfactory following mitral repair at midterm follow-up. These scores may guide frequency of follow-up and timing of further mitral reintervention.
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